- Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder.
Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder.
The Journal of pharmacology and experimental therapeutics (2016-12-15)
J Di Salvo, H Nagabukuro, L A Wickham, C Abbadie, J A DeMartino, A Fitzmaurice, L Gichuru, A Kulick, M J Donnelly, N Jochnowitz, A L Hurley, A Pereira, A Sanfiz, G Veronin, K Villa, J Woods, B Zamlynny, E Zycband, G M Salituro, T Frenkl, A E Weber, S D Edmondson, M Struthers
PMID27965369
RESUMEN
Although the physiologic role of muscarinic receptors in bladder function and the therapeutic efficacy of muscarinic antagonists for the treatment of overactive bladder are well established, the role of β
MATERIALES
Número de producto
Marca
Descripción del producto
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Kits y reactivos de triglicéridos y glicerol libre, 1 kit sufficient for 1000 reactions
En este momento no podemos mostrarle ni los precios ni la disponibilidad
En este momento no podemos mostrarle ni los precios ni la disponibilidad
En este momento no podemos mostrarle ni los precios ni la disponibilidad